These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 4097281)
21. BAY K 8644 and nifedipine alter halothane but not caffeine contractures of malignant hyperthermic muscle fibers. Williams JH; Holland M; Lee JC; Ward CW; McGrath CJ Am J Physiol; 1991 Oct; 261(4 Pt 2):R782-6. PubMed ID: 1718170 [TBL] [Abstract][Full Text] [Related]
22. Diltiazem inhibits halothane-induced contractions in malignant hyperthermia-susceptible muscles in vitro. Ilias WK; Williams CH; Fulfer RT; Dozier SE Br J Anaesth; 1985 Oct; 57(10):994-6. PubMed ID: 4041327 [TBL] [Abstract][Full Text] [Related]
23. Propofol is a 'safe' anaesthetic agent in malignant hyperthermia susceptible patients. McKenzie AJ; Couchman KG; Pollock N Anaesth Intensive Care; 1992 May; 20(2):165-8. PubMed ID: 1595850 [TBL] [Abstract][Full Text] [Related]
24. [In vitro diagnosis of malignant hyperpyrexia syndrome]. Eldar I; Goldberg G; Glauber V; Perel A Harefuah; 1991 Dec; 121(12):499-502. PubMed ID: 1794753 [TBL] [Abstract][Full Text] [Related]
25. Effect of cocaine on the contracture response to 1% halothane in patients undergoing diagnostic muscle biopsy for malignant hyperthermia. Sato N; Brum JM; Mitsumoto H; DeBoer GE Can J Anaesth; 1995 Feb; 42(2):158-62. PubMed ID: 7720160 [TBL] [Abstract][Full Text] [Related]
26. In vitro responses of cat skeletal muscle to halothane and caffeine. Deuster PA; Bockman EL; Muldoon SM J Appl Physiol (1985); 1985 Feb; 58(2):521-7. PubMed ID: 3980355 [TBL] [Abstract][Full Text] [Related]
27. Malignant hyperthermia in China. Xu ZH; Luo AL; Guo XY; Ren HZ; Wang YL; Zhang X; Huang YG; Ye TH Anesth Analg; 2006 Oct; 103(4):983-5. PubMed ID: 17000816 [TBL] [Abstract][Full Text] [Related]
33. [Diagnosis of susceptibility for malignant hyperthermia using in-vitro muscle contraction testing in Switzerland]. Urwyler A; Censier K; Seeberger MD; Drewe J; Rothenbühler JM; Frei F Schweiz Med Wochenschr; 1991 Apr; 121(16):566-71. PubMed ID: 2042040 [TBL] [Abstract][Full Text] [Related]
34. Calcium content and contracture in isolated muscle of malignant hyperthermia in pigs. Nelson TE; Chausmer AB J Pharmacol Exp Ther; 1981 Oct; 219(1):107-11. PubMed ID: 7288598 [No Abstract] [Full Text] [Related]
35. Diagnosis of susceptibility to malignant hyperthermia in man. Ording H Br J Anaesth; 1988 Feb; 60(3):287-302. PubMed ID: 3279989 [No Abstract] [Full Text] [Related]
36. Effects of the calcium antagonist, TMB-8 on halothane and on caffeine contractures of malignant hyperthermia susceptible skeletal muscle. Williams JH; Holland M; Lee JC Res Commun Chem Pathol Pharmacol; 1990 Jun; 68(3):387-90. PubMed ID: 2385762 [TBL] [Abstract][Full Text] [Related]
37. A study of the action of caffeine, halothane, potassium chloride and procaine on normal human skeletal muscle. Moulds RF; Denborough MA Clin Exp Pharmacol Physiol; 1974; 1(3):197-209. PubMed ID: 4458993 [No Abstract] [Full Text] [Related]
38. The in vitro determination of susceptibility to malignant hyperthermia. Iaizzo PA; Lehmann-Horn F Muscle Nerve; 1989 Mar; 12(3):184-90. PubMed ID: 2725548 [TBL] [Abstract][Full Text] [Related]
39. Viability criterion of muscle bundles used in the in vitro contracture test in patients with neuromuscular diseases. Adnet PJ; Krivosic-Horber RM; Krivosic I; Haudecoeur G; Reyford HG; Adamantidis MM; Medahoui H Br J Anaesth; 1994 Jan; 72(1):93-7. PubMed ID: 8110560 [TBL] [Abstract][Full Text] [Related]
40. A case of neuroleptic malignant syndrome: in vitro muscle comparison with malignant hyperthermia. Tollefson G J Clin Psychopharmacol; 1982 Aug; 2(4):266-70. PubMed ID: 6126494 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]